Pharmaco-transcriptomicsUp/down regulation of genes due to the metabolism of pharmaceutical compounds

Pharmaco-genomics Pharmaco-metabolomics Pharmaco-transcriptomics Pharmaco-proteomics Search

Displaying entries 70701 - 70725 of 102031 in total

Drug	Drug Groups	Gene	Gene ID	Change	Interaction	Chromosome	References
							Clear
Silicon dioxide	Approved	GATA6	2627	downregulated	Silicon Dioxide analog results in decreased expression of GATA6 mRNA	18q11.2	A24195
Silicon dioxide	Approved	GATAD1	57798	downregulated	Silicon Dioxide results in decreased expression of GATAD1 mRNA	7q21.2	A24196
Silicon dioxide	Approved	GATAD2A	54815	upregulated	Silicon Dioxide analog results in increased expression of GATAD2A mRNA	19p13.11	A24195
Silicon dioxide	Approved	GATM	2628	upregulated	Silicon Dioxide results in increased expression of GATM mRNA	15q21.1	A24207
Silicon dioxide	Approved	GATS	352954	downregulated	Silicon Dioxide analog results in decreased expression of GATS mRNA	7q22.1	A24195
Silicon dioxide	Approved	GBA3	57733	downregulated	Silicon Dioxide analog results in decreased expression of GBA3 mRNA	4p15.2	A24195
Silicon dioxide	Approved	GBP1	2633	upregulated	Silicon Dioxide results in increased expression of GBP1 mRNA	1p22.2	A24196
Silicon dioxide	Approved	GBP2	2634	downregulated	Silicon Dioxide analog results in decreased expression of GBP2 mRNA	1p22.2	A24195
Silicon dioxide	Approved	GBP3	2635	downregulated	Silicon Dioxide analog results in decreased expression of GBP3 mRNA	1p22.2	A24195
Silicon dioxide	Approved	GCA	25801	downregulated	Silicon Dioxide analog results in decreased expression of GCA mRNA	2q24.2	A24195
Silicon dioxide	Approved	GCAT	23464	downregulated	Silicon Dioxide results in decreased expression of GCAT mRNA	22q13.1	A24196
Silicon dioxide	Approved	GCC2	9648	downregulated	Silicon Dioxide analog results in decreased expression of GCC2 mRNA	2q12.3	A24195
Silicon dioxide	Approved	GCH1	2643	upregulated	Silicon Dioxide analog results in increased expression of GCH1 mRNA	14q22.2	A24195
Silicon dioxide	Approved	GCHFR	2644	downregulated	Silicon Dioxide analog results in decreased expression of GCHFR mRNA	15q15.1	A24195
Silicon dioxide	Approved	GCLC	2729	downregulated	Silicon Dioxide analog results in decreased expression of GCLC mRNA	6p12.1	A24195
Silicon dioxide	Approved	GCNT3	9245	downregulated	Silicon Dioxide results in decreased expression of GCNT3 mRNA	15q22.2	A24196
Silicon dioxide	Approved	GCOM1	145781	upregulated	Silicon Dioxide analog results in increased expression of GCOM1 mRNA	15q21.3	A24195
Silicon dioxide	Approved	GDA	9615	downregulated	Silicon Dioxide analog results in decreased expression of GDA mRNA	9q21.13	A24195
Silicon dioxide	Approved	GDF15	9518	upregulated	Silicon Dioxide analog results in increased expression of GDF15 mRNA	19p13.11	A24194
Silicon dioxide	Approved	GDNF	2668	downregulated	Silicon Dioxide analog results in decreased expression of GDNF mRNA	5p13.2	A24194
Silicon dioxide	Approved	GDPD5	81544	downregulated	Silicon Dioxide analog results in decreased expression of GDPD5 mRNA	11q13.4-q13.5	A24195
Silicon dioxide	Approved	GEM	2669	upregulated	Silicon Dioxide analog results in increased expression of GEM mRNA	8q22.1	A24194 A24195
Silicon dioxide	Approved	GEM	2669	upregulated	Silicon Dioxide results in increased expression of GEM mRNA	8q22.1	A24197 A24196
Silicon dioxide	Approved	GFER	2671	upregulated	Silicon Dioxide analog results in increased expression of GFER mRNA	16p13.3	A24195
Silicon dioxide	Approved	GFOD1	54438	upregulated	Silicon Dioxide analog results in increased expression of GFOD1 mRNA	6p24.1-p23	A24195

Displaying entries 70701 - 70725 of 102031 in total

Pharmaco-transcriptomicsUp/down regulation of genes due to the metabolism of pharmaceutical compounds

Advanced Filter

Filter by Group

Filter by Market Availability